hepatitis b surface antigen
SpainDrugs containing this active substance
-
It is used to protect against hepatitis B infection and can also help protect against hepatitis D infection.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage hepatitis b surface antigen 20 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to protect against hepatitis B infection and may also help protect against hepatitis D infection.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage hepatitis b surface antigen 10 µg Manufacturer: Glaxosmithkline S.A.
-
It is a vaccine used to prevent hepatitis B, especially in adults and young people aged 15 and older who have kidney problems, such as patients undergoing hemodialysis or those who will undergo it in the future.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage hepatitis b surface antigen 20 µg Manufacturer: Glaxosmithkline Biologicals
-
It is used for active immunization against hepatitis B virus infection in individuals aged 16 years and older who are at risk of exposure to the virus. It may also help prevent hepatitis D.
Form: suspension for injection
Active substance Dosage hepatitis b surface antigen 10 µg Manufacturer: Merck Sharp & Dohme B.V.
-
It is used for active immunization against hepatitis B virus infection in adult patients undergoing pre-dialysis or dialysis. It may also help prevent hepatitis D.
Form: suspension for injection
Active substance Dosage hepatitis b surface antigen 0,04 mg Manufacturer: Merck Sharp & Dohme B.V.
-
It is used for active immunization against hepatitis B virus infection in individuals from birth to 15 years of age who are at risk of exposure to the virus. It is also expected to help prevent hepatitis D.
Form: suspension for injection
Active substance Dosage hepatitis b surface antigen 5 µg Manufacturer: Merck Sharp & Dohme B.V.
-
It is a vaccine that helps protect children from six weeks of age against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and serious diseases caused by Haemophilus influenzae type b.
Form: suspension for injection
Active substance Dosage diphtheria toxoid 20 UI tetanus toxoid 40 UI bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg inactivated poliovirus type 1 mahoney produced in vero cells 40 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 8 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg haemophilus influenzae type b capsular polysaccharide prp 12 µg Manufacturer: Sanofi Winthrop Industrie
-
It is a vaccine that helps protect children from six weeks of age against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and serious diseases caused by Haemophilus influenzae type b.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage tetanus toxoid 40 UI bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg inactivated poliovirus type 1 mahoney produced in vero cells 40 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 8 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg h. influenzae type b polysaccharide tetanus toxoid conjugate 12 µg diphtheria toxoid 20 UI Manufacturer: Sanofi Winthrop Industrie
-
It is a vaccine that helps protect children from six weeks of age against diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis, and serious diseases caused by Haemophilus influenzae type b.
Form: suspension for injection
Active substance Dosage diphtheria toxoid 20 UI tetanus toxoid 40 UI bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg inactivated poliovirus type 1 mahoney produced in vero cells 40 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 8 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg haemophilus influenzae type b capsular polysaccharide prp 12 µg Manufacturer: Sanofi Winthrop Industrie
-
This vaccine is used to protect children against six diseases: diphtheria, tetanus, pertussis, hepatitis B, polio, and Haemophilus influenzae type b (Hib) infection.
Form: powder and solvent for injectable suspension
Active substance Dosage diphtheria toxoid 30 UI tetanus toxoid 40 UI h. influenzae type b polysaccharide tetanus toxoid conjugate 0,02 mg haemophilus influenzae type b 0,01 mg bordetella pertussis toxoid 0,025 mg bordetella pertussis filamentous hemagglutinin 0,025 mg bordetella pertussis 69 kd outer membrane protein 0,01 mg poliovirus type i 40 U.D. (UNIDADES ANTIGENICAS D) poliovirus type ii 8 U.D. (UNIDADES ANTIGENICAS D) poliovirus type iii 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 0,01 mg Manufacturer: Glaxosmithkline Biologicals
-
This vaccine is used to protect children against six diseases: diphtheria, tetanus, pertussis, hepatitis B, polio, and Haemophilus influenzae type b (Hib) infection.
Form: powder and solvent for injectable suspension
Active substance Dosage diphtheria toxoid 30 UI tetanus toxoid 40 UI h. influenzae type b polysaccharide tetanus toxoid conjugate 20 µg haemophilus influenzae type b 10 µg bordetella pertussis toxoid 25 µg bordetella pertussis filamentous hemagglutinin 25 µg bordetella pertussis 69 kd outer membrane protein 10 µg poliovirus type i 40 U.D. (UNIDADES ANTIGENICAS D) poliovirus type ii 8 U.D. (UNIDADES ANTIGENICAS D) poliovirus type iii 32 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg Manufacturer: Glaxosmithkline Biologicals
-
This vaccine is used in adults and adolescents aged 16 years or older to prevent hepatitis A and hepatitis B.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage hepatitis a antigen 720 U ELISA hepatitis b surface antigen 20 µg Manufacturer: Glaxosmithkline Biologicals
-
It is used in children and adolescents between 1 and 15 years of age to prevent hepatitis A and hepatitis B, helping the body produce its own antibodies against these diseases.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage hepatitis a antigen 360 U ELISA hepatitis b surface antigen 10 µg Manufacturer: Glaxosmithkline Biologicals
-
This vaccine helps protect children against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and serious diseases caused by Haemophilus influenzae type b.
Form: suspension for injection, in pre-filled syringe
Active substance Dosage diphtheria toxoid Mayor o igual a 20 UI tetanus toxoid Mayor o igual a 40 UI bordetella pertussis toxoid 20 µg bordetella pertussis filamentous hemagglutinin 20 µg bordetella pertussis pertactin 3 µg pertussis fimbriae agglutinogen toxoid 5 µg inactivated poliovirus type 1 mahoney produced in vero cells 29 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 2 mef-1 produced in vero cells 7 U.D. (UNIDADES ANTIGENICAS D) inactivated poliovirus type 3 saukett produced in vero cells 26 U.D. (UNIDADES ANTIGENICAS D) hepatitis b surface antigen 10 µg conjugate haemophilus influenzae prp-neisseria meningitidis ompc 3 µg Manufacturer: Mcm Vaccine B.V.